Breaking New Ground in Predicting Psoriatic Arthritis
Shownotes
How close are we to predicting psoriatic arthritis (PsA) before it strikes? In this episode of Inside GRAPPA, Dr. Fabian Proft sits down with two esteemed researchers, Dr. Axel Svedbom and Professor Mona Ståhle, from the Karolinska Institute in Stockholm, to discuss their groundbreaking study on predicting PsA in patients with new-onset psoriasis. Funded by the GRAPPA Pilot Research Grant, this project is poised to revolutionize early detection and intervention strategies for psoriatic disease.
Listen as they discuss:
- The innovative predictive models combining machine learning with clinical data.
- Key findings, including the significance of arthralgia as a predictive marker for PsA.
- How their research could reshape clinical practices and improve patient outcomes.
- Dr. Axel Svedbom: Postdoctoral researcher specializing in registry-based research and health economics, with over a decade of focus on psoriasis and psoriatic arthritis.
- Professor Mona Ståhle: Dermatologist and researcher dedicated to advancing understanding and treatment of psoriatic disease.
- Stay updated with GRAPPA's initiatives: GRAPPA Website.
- Explore previous episodes of Inside GRAPPA: Podcast Archive.
🎙️ Subscribe to Inside GRAPPA and join the conversation!
Hosted on Acast. See acast.com/privacy for more information.